Login
Navigate Fool.com
Will PRXL beat
the market?
Community Rating: 5 Stars: The Best

46.71 -0.12 (-0.26%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.90
Previous Close $46.83
Daily Range $46.50 - $47.18
52-Week Range $25.11 - $47.23
Market Cap $2.7B
P/E Ratio 33.45
Dividend (Yield) $0.00 (0.0%)
Volume 551,978
Average Daily Volume 515,620
Current FY EPS $1.62

How do you think PRXL
will perform against the market?

Top PRXL Bull/Bear Pitches

 

BobLangley (< 20)
Submitted October 21, 2008

Considerable backlog exists for the services of this clinical research and marketing company whose stock has taken an unjustified hit of late.

0 Replies Reply Report this Post
 

PennyStockFool (< 20)
Submitted January 27, 2009

Taking today's (1/27) 30% gain on this stock and going Thumbs Down for a few weeks.

0 Replies Reply Report this Post

News & Commentary Rss Feed

Is PAREXEL International a Cash Machine?

All cash flow is not created equal.

Cabot’s Sense of Fair Play

Taking Charge of Your Retirement

PAREXEL Makes an Acquisition

The price tag for HERON is $24 million, plus a potential extra $14.2 million.

Has PAREXEL International Made You Any Real Money?

All cash flow is not created equal.

Long-Term Deals With Drug Makers Help Icon's Earnings

Some Numbers at PAREXEL International that Make Your Stock Look Good

Look here for a clue.

Here's How PAREXEL International May Be Failing You

Keep your eye on margins.

Short Candidates for Contrarians, Part 3

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

See More PRXL News...

Sector

Healthcare

Industry

Healthcare Information Services

PAREXEL International Corp (PRXL) Description

The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Website: http://www.parexel.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks